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Creating materials to aid regenerative medicine
by Julie O’Connor

About Dr. David Oupicky:
Dr. Oupicky received a M.S. in polymer engineering
from the Institute of Chemical Technology, Prague,
and his Ph.D. in macromolecular chemistry from the

magine a time in the future when human
lifespan is extended because “broken parts” are
simply replaced by regenerated ones. Lives may
be lengthened by several decades because of new
technologies that create cells, tissues and organs for
patients who may need them. Research at Wayne
State is putting us closer to the day when this
will happen.
The development of biomaterial scaffolds plays a
central role in regenerative medicine by providing
the chemical, biological and mechanical cues
necessary for tissue formation or regeneration.
Successful regeneration strategies require a distinct
sequence of phases driven by multiple signals with
appropriate spatial and temporal control. This creates
a major challenge in how to design materials that
direct the growth, differentiation and organization of
cells in the process of forming new tissue.
A multidisciplinary team of collaborators from the
Eugene Applebaum College of Pharmacy and Health
Sciences and the College of Engineering is combining
their expertise to develop thin DNA films that can
be easily deposited onto the surface of a wide range
of biomaterial “scaffolds” by a sophisticated delivery
method of multiple therapeutic genes triggered by
cell attachment.
“Successful tissue regeneration depends on
the right combination and sequence of pieces of
information that have to be provided to the cells
so that they can grow, differentiate and organize
themselves into a functional tissue or organ,”
said David Oupicky, Ph.D., associate professor
of pharmaceutical sciences. “We have developed
multilayered films consisting of multiple genes
that serve as those pieces of information telling the
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cells what to do and when to do it. The films are
unique in that they provide an unprecedented level
of control over the sequence of the signals. The
films are also universally applicable to virtually any
combination of genes, which makes them applicable
to a large variety of tissue regeneration strategies.”
Because the study requires a wide range of
expertise ranging from material synthesis and
characterization to biological evaluation, it was
critical for Oupicky to collaborate to nurture and
develop smart biomaterials. Dr. Guangzhao Mao,
professor of chemical engineering and materials
science in the College of Engineering, and her
research lab had the right blend of knowledge to
guide the characterizing of materials.
Once Mao’s group makes the DNA-containing
films, they characterize them to ensure
reproducibility of the film-making method. “We
characterize the films to determine film thickness,
surface roughness, chemical composition and
mechanical properties because all these factors
will impact the film’s ultimate use as coatings for
localized gene delivery,” said Mao.
According to Mao, this collaborative team has
obtained preliminary results that show the films
are promoting cell attachment and gene expression,
and they expect to apply this technology for
regenerative medicine.
The team’s future goals are to focus on
incorporating multiple DNA plasmids instead of
single reporter genes into the layer-by-layer thin
films. These can then be transcribed sequentially into
functional proteins inside human diseased cells. The
newly produced proteins will play the role of treating
and preventing diseases.
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“We have great expectations for this technology,”
said Oupicky. “We are at a stage where we have
confirmed in vivo feasibility and safety of our
approach.” The next step, according to Oupicky, is to
form new collaborations with clinical researchers and
start a more translational development of these films.
Through their efforts, Oupicky and Mao are one step
closer to providing a sophisticated delivery method
suitable for regeneration of bone, neural tissue
and more.
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